Internal Medicine 919 - Internal Medicine Alert - Oct 15, 2005

Target Audience:

This activity is intended for the internist and family practitioner.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


  • Even If You Use It, You May Lose It!
  • Effect of a New Diagnosis of Barrett’s Esophagus on Insurance Status
  • Increased Dietary Intake of Folate Reduces the Risk of Developing Alzheimer’s Disease
  • Pharmacology Update: Ramelteon Tablets (Rozerem™)
  • Clinical Briefs
  • ECG Review: When Did the Chest Pain Begin?


  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens

Financial Disclosure:

Internal Medicine Alert’s Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca and serves on the speaker’s bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil.